These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 12867218

  • 1. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
    Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.
    Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [Abstract] [Full Text] [Related]

  • 3. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, Hwu HG.
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [Abstract] [Full Text] [Related]

  • 4. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H, Gen K, Takahashi Y.
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [Abstract] [Full Text] [Related]

  • 5. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
    Battaglia J, Houston JP, Ahl J, Meyers AL, Kaiser CJ.
    Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A.
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
    Chan HY, Ree SC, Su LW, Chen JJ, Chou SY, Chen CK, Chen YS.
    J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
    [Abstract] [Full Text] [Related]

  • 8. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 9. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
    Castle DJ, Udristoiu T, Kim CY, Sarosi A, Pidrman V, Omar AN, Rosales JI, Melamed Y, Isik T, Karagianis J, Treuer T.
    World J Biol Psychiatry; 2009 May; 10(1):43-53. PubMed ID: 19137460
    [Abstract] [Full Text] [Related]

  • 10. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [Abstract] [Full Text] [Related]

  • 11. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B, Taylor CC, Meehan K.
    J Clin Psychiatry; 2001 May; 62 Suppl 2():22-4. PubMed ID: 11232747
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
    Katagiri H, Fujikoshi S, Suzuki T, Fujita K, Sugiyama N, Takahashi M, Gomez JC.
    BMC Psychiatry; 2013 Jan 11; 13():20. PubMed ID: 23311957
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
    Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A.
    J Clin Psychopharmacol; 2001 Aug 11; 21(4):389-97. PubMed ID: 11476123
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug 11; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 17. Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
    Lindborg SR, Beasley CM, Alaka K, Taylor CC.
    Psychiatry Res; 2003 Jul 15; 119(1-2):113-23. PubMed ID: 12860365
    [Abstract] [Full Text] [Related]

  • 18. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T.
    Psychopharmacology (Berl); 2006 Oct 15; 188(3):281-92. PubMed ID: 16953381
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses.
    Belgamwar RB, Fenton M.
    Cochrane Database Syst Rev; 2005 Apr 18; 2005(2):CD003729. PubMed ID: 15846678
    [Abstract] [Full Text] [Related]

  • 20. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov 18; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.